NDC 69097-361

grisofulvin 125 mg per 5 mL suspension

On the label: Cipla USA., Inc..

China: 1India: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Chifeng Pharmaceutical Co. LtdChifeng, ChinaMakes the active ingredient Problems found, fixed voluntarilyJan 19, 2024 · 5 inspections
Cipla LimitedIndore, IndiaMakes it, tests it, packages it and labels it Serious problems, FDA actionFeb 17, 2023 · 6 inspections, 1 with FDA action

Product details

Generic drug
Griseofulvin: every company that makes it
Form
suspension, oral
Strength
125 mg per 5 mL
Approval
ANDA ANDA065354
On the market since
Mar 6, 2017
Package NDCs
69097-361-08
Official label
DailyMed (National Library of Medicine), updated Mar 27, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?